Simplex Trading
GILD icon

Simplex Trading’s Gilead Sciences GILD Stock Holding History

Simplex Trading’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$45.1M Buy
323,900
+101,500
+46% +$14.2M 0.03% 244
2025
Q4 		$27.3M Sell
222,400
-48,700
-18% -$5.92M 0.02% 444
2025
Q3 		$30.1M Sell
271,100
-41,700
-13% -$4.74M 0.02% 486
2025
Q2 		$34.7M Sell
312,800
-161,800
-34% -$17.2M 0.02% 378
2025
Q1 		$53.2M Buy
474,600
+177,600
+60% +$18.3M 0.03% 267
2024
Q4 		$27.4M Sell
297,000
-111,100
-27% -$10M 0.02% 492
2024
Q3 		$34.2M Sell
408,100
-113,400
-22% -$8.65M 0.02% 421
2024
Q2 		$35.8M Buy
521,500
+71,300
+16% +$4.76M 0.02% 401
2024
Q1 		$33M Buy
450,200
+100,500
+29% +$7.73M 0.02% 474
2023
Q4 		$28.3M Buy
349,700
+29,000
+9% +$2.26M 0.02% 561
2023
Q3 		$24M Sell
320,700
-116,100
-27% -$8.93M 0.02% 510
2023
Q2 		$33.7M Sell
436,800
-100,600
-19% -$8.02M 0.03% 370
2023
Q1 		$44.6M Sell
537,400
-37,300
-6% -$3.09M 0.04% 315
2022
Q4 		$49.3M Sell
574,700
-87,400
-13% -$6.92M 0.05% 275
2022
Q3 		$40.8M Buy
662,100
+116,800
+21% +$7.37M 0.05% 303
2022
Q2 		$33.7M Sell
545,300
-472,600
-46% -$29.3M 0.04% 345
2022
Q1 		$60.5M Buy
1,017,900
+247,200
+32% +$15.8M 0.06% 247
2021
Q4 		$56M Buy
770,700
+13,700
+2% +$944K 0.06% 256
2021
Q3 		$52.3M Buy
757,000
+88,800
+13% +$6.24M 0.05% 237
2021
Q2 		$46M Buy
+668,200
New +$44.6M 0.04% 252
2021
Q1 		– Sell
-6,249
Closed -$36.4M – 9225
2020
Q4 		$36.4M Sell
6,249
-7,029
-53% -$424K 0.05% 226
2020
Q3 		$83.9M Sell
13,278
-2,597
-16% -$180K 0.11% 100
2020
Q2 		$122M Buy
15,875
+4,416
+39% +$338K 0.19% 57
2020
Q1 		$85.7M Buy
11,459
+5,923
+107% +$409K 0.15% 59
2019
Q4 		$36M Buy
5,536
+1,415
+34% +$92.1K 0.08% 159
2019
Q3 		$26.1M Sell
4,121
-371
-8% -$24.3K 0.07% 194
2019
Q2 		$30.3M Buy
4,492
+219
+5% +$14.4K 0.08% 148
2019
Q1 		$27.8M Sell
4,273
-6,696
-61% -$445K 0.08% 160
2018
Q4 		$68.6M Buy
10,969
+6,496
+145% +$454K 0.2% 59
2018
Q3 		$34.5M Buy
4,473
+1,130
+34% +$85.3K 0.11% 122
2018
Q2 		$23.7M Sell
3,343
-715
-18% -$50.5K 0.09% 150
2018
Q1 		$490K Sell
4,058
-2,027
-33% -$161K 0.02% 728
2017
Q4 		$389K Sell
6,085
-2,131
-26% -$162K 0.02% 853
2017
Q3 		$3.44M Buy
8,216
+1,027
+14% +$78.5K 0.14% 113
2017
Q2 		$1.75M Buy
7,189
+927
+15% +$61.7K 0.08% 206
2017
Q1 		$959K Buy
6,262
+56
+0.9% +$3.94K 0.04% 400
2016
Q4 		$853K Buy
6,206
+1,166
+23% +$86.7K 0.05% 310
2016
Q3 		$1M Buy
5,040
+907
+22% +$73.7K 0.07% 260
2016
Q2 		$822K Sell
4,133
-1,863
-31% -$165K 0.05% 344
2016
Q1 		$1.94M Buy
5,996
+3,635
+154% +$328K 0.15% 119
2015
Q4 		$1.28M Sell
2,361
-4,113
-64% -$428K 0.1% 168
2015
Q3 		$1.63M Buy
6,474
+1,745
+37% +$194K 0.12% 149
2015
Q2 		$3.73M Sell
4,729
-2,008
-30% -$219K 0.31% 49
2015
Q1 		$1.84M Sell
6,737
-157
-2% -$15.9K 0.21% 91
2014
Q4 		$8.16M Buy
+6,894
New +$713K 0.99% 12

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Simplex Trading's GILD Position: Q3 2025 in Review

Simplex Trading sold out of Gilead Sciences (GILD) in Q3 2025, closing a stake of 26,577 shares — an estimated $3.02M sold.

Simplex Trading first reported a position in GILD in Q4 2014 and held it in 33 quarters. The position peaked at $32.5M in Q1 2017. 2,026 funds tracked by Wall St. Rank hold GILD as of Q3 2025.

  • Simplex Trading reported no remaining Gilead Sciences position as of Q3 2025 after selling out during the quarter.
  • Simplex Trading sold 26,577 Gilead Sciences shares in Q3 2025, an estimated $3.02M.
  • Simplex Trading first reported a position in Gilead Sciences in Q4 2014 and held it in 33 quarters.
  • Simplex Trading's Gilead Sciences position peaked at $32.5M in Q1 2017.
  • 2,026 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2025.

Based on Simplex Trading's 13F filing for Q3 2025, filed 12 Nov 2025.